Comparison of tenofovir, zidovudine, or stavudine as part of first-line antiretroviral therapy in a resource-limited-setting: a cohort study.

<h4>Background</h4>Tenofovir (TDF) is part of the WHO recommended first-line antiretroviral therapy (ART); however, there are limited data comparing TDF to other nucleoside reverse transcriptase inhibitors in resource-limited-settings. Using a routine workplace and community-based ART co...

Full description

Bibliographic Details

Published in:	PLoS ONE
Main Authors:	Kavindhran Velen, James J Lewis, Salome Charalambous, Alison D Grant, Gavin J Churchyard, Christopher J Hoffmann
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2013-01-01
Online Access:	https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0064459&type=printable